These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26573712)

  • 1. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
    Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
    Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
    Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
    Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
    Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
    Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
    Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
    J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
    Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
    Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
    Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
    Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway.
    Deng KQ; Li J; She ZG; Gong J; Cheng WL; Gong FH; Zhu XY; Zhang Y; Wang Z; Li H
    Hypertension; 2017 Oct; 70(4):770-779. PubMed ID: 28827473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.
    Jiang DS; Bian ZY; Zhang Y; Zhang SM; Liu Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
    Hypertension; 2013 Jun; 61(6):1193-202. PubMed ID: 23589561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
    Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
    Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
    Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
    Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.
    Zhou H; Shen DF; Bian ZY; Zong J; Deng W; Zhang Y; Guo YY; Li H; Tang QZ
    PLoS One; 2011; 6(10):e26744. PubMed ID: 22053207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
    Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
    Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.